# DEXTROAMPHETAMINE SACCHARATE; AMPHETAMINE ASPARTATE MONOHYDRATE; DEXTROAMPHETAMINE SULFATE; AMPHETAMINE SULFATE
> **ANDA206304** · Abbreviated New Drug Application (Generic) · Sponsor: COREPHARMA · Approved 2016-04-15
## Drug
- **FDA Application Number:** ANDA206304
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** DEXTROAMPHETAMINE SACCHARATE; AMPHETAMINE ASPARTATE MONOHYDRATE; DEXTROAMPHETAMINE SULFATE; AMPHETAMINE SULFATE
- **Generic name:** Dextroamphetamine Saccharate
- **Active ingredients:** DEXTROAMPHETAMINE SACCHARATE; AMPHETAMINE ASPARTATE MONOHYDRATE; DEXTROAMPHETAMINE SULFATE; AMPHETAMINE SULFATE
- **Dosage form:** CAPSULE, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** COREPHARMA
- **First approval:** 2016-04-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206304)
---
*AI Analytics · CC0 1.0*